ViewRay®, Inc. (NASDAQ:VRAY), designs, manufactures, and markets the MRIdian® radiation therapy system to address the key limitations of existing external-beam radiation therapy technologies. MRIdian employs MRI-based technology to provide real-time imaging that clearly defines the targeted tumor from the surrounding soft tissue and other critical organs during radiation treatment. MRIdian allows physicians to record the level of radiation exposure that the tumor has received and adapt the prescription as needed. ViewRay believes this combination of enhanced visualization, on-line adapting and accurate dose recording will significantly improve the safety and efficacy of radiation therapy, leading to better outcomes for patients.
Type
Public
HQ
Oakwood Village, US
Founded
2004
Employees
106 (est)
ViewRay was founded in 2004 and is headquartered in Oakwood Village, US

Key People at ViewRay

Stephen J. Strunk

Stephen J. Strunk

Vice President of Manufacturing
Michael Brandt

Michael Brandt

Senior Vice President of Sales
Chris A. Raanes

Chris A. Raanes

President and CEO
Gopinath Kuduvalli

Gopinath Kuduvalli

Vice President of Engineering

ViewRay Locations

Oakwood Village, US
Cleveland, US
Mountain View, US
Mountain View, US

ViewRay Metrics

ViewRay Summary

Market capitalization

$160 M

Closing share price

$3.63
ViewRay's latest market capitalization is $160 M.

ViewRay Market Value History

ViewRay Online Presence

ViewRay Company Life